PMID: 6145104Apr 1, 1984

Role of beta 2-adrenoceptor blockade and circulating adrenaline level for the pressor responses to beta-adrenoceptor blocking drugs in rats

Naunyn-Schmiedeberg's Archives of Pharmacology
N HimoriA Izumi

Abstract

The present experiments were designed to elucidate what mechanism(s) would be responsible for beta-adrenoceptor blocking drugs (beta-blockers)-induced pressor responses in rats. In urethane-anaesthetized rats, 6 beta-blockers at i.v. doses ranging from 0.3 to 300 micrograms/kg evoked the pressor response in a dose-dependent manner. The relative potency in causing the pressor action was correlated not to their beta 1-blocking activities (r = 0.374, P greater than 0.05) but to their beta 2-blocking ones (r = 0.856, P less than 0.05). In pithed or adrenalectomized rats with low levels of plasma catecholamines, however, propranolol failed to exert its sustained pressor action. Propranolol (300 micrograms/kg i.v.) distinctly potentiated the pressor responses not to noradrenaline but to adrenaline and to electrical stimulation of the sympathetic outflow (E.S.) in pithed rats. On the contrary, there was not any potentiation of pressor response to E.S. in pithed, adrenalectomized rats treated with propranolol (300 micrograms/kg i.v.). In rats treated with phenoxybenzamine (5 mg/kg i.v.), adrenaline was shown to have much more potent vasodilating action resulting from beta 2-stimulation than noradrenaline, the dose difference for causin...Continue Reading

References

Jul 19, 1975·British Medical Journal·H J Waal-Manning, F O Simpson
Dec 13, 1975·British Medical Journal·I BlumH Wysenbeek
Apr 1, 1974·Japanese Journal of Pharmacology·J Yamamoto, A Sekiya
Jan 15, 1974·Naunyn-Schmiedeberg's Archives of Pharmacology·H Karppanen
May 1, 1967·British Journal of Pharmacology and Chemotherapy·J S Gillespie, T C Muir
Nov 1, 1970·British Journal of Pharmacology·A M Barrett, J Carter
Jan 1, 1974·Clinical and Experimental Pharmacology & Physiology·G J Dusting, M J Rand
Sep 1, 1973·Clinical Pharmacology and Therapeutics·A S Nies, D G Shand
Jul 1, 1970·Canadian Journal of Physiology and Pharmacology·D Regoli
Oct 1, 1966·British Journal of Pharmacology and Chemotherapy·S O Kayaalp, B K Kiran
Apr 4, 1980·European Journal of Pharmacology·K SugawaraM Ozaki

Citations

Jul 5, 1994·Biochemical Pharmacology·B N WuI J Chen
May 31, 1990·European Journal of Pharmacology·A AbdelrahmanC C Pang
Jul 1, 1994·General Pharmacology·B N WuI J Chen
Oct 1, 1990·The Journal of Pharmacy and Pharmacology·M KazanietzM A Enero
Jan 1, 1992·The Journal of Pharmacy and Pharmacology·A AbdelrahmanC C Pang

Related Concepts

Adrenalectomy
Adrenergic beta-Antagonists
Diastolic Blood Pressure
Decorticate State
Electric Stimulation Technique
Medihaler-Epi
Pulse Rate
Novodrin
Norepinephrine, (+, -)-Isomer
Rexigen

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.